| Multiple | Now | Sector median | Where it sits |
|---|---|---|---|
| P/E | −10.4× | −1.8× | |
| Price / Book | 0.5× | 2.1× | |
| Price / Sales | 1.0× | 4.0× | |
| Price / Free cash flow | −11.2× | −1.6× | |
| EV / EBITDA | −11.2× | −1.1× | |
| Earnings yield | −9.6% | −14.1% | |
| Free cash flow yield | −8.9% | −9.6% |
| Company | Price | Change | Mkt cap (USD) | P/E | ROE | 1Y |
|---|---|---|---|---|---|---|
LL |
| $1,285.00 |
| −1.66% |
| $1.21T |
| 59.6× |
| 77.8% |
| +21.1% |
JNNYSE:JNJJohnson & Johnson · 🇺🇸 NYSE | $264.27 | −1.25% | $636.18B | 24.0× | 32.9% | +39.5% |
ABNYSE:ABBVAbbVie Inc · 🇺🇸 NYSE | $283.46 | −0.61% | $500.91B | 119.3× | −129.2% | +23.3% |
UNNYSE:UNHUnitedHealth Group Inc · 🇺🇸 NYSE | $423.24 | −0.41% | $379.9B | 31.6× | 12.8% | +16.3% |
MRNYSE:MRKMerck & Co Inc · 🇺🇸 NYSE | $144.27 | −2.02% | $355.94B | 19.9× | 34.7% | +68.0% |
NVNYSE:NVSNovartis AG · 🇺🇸 NYSE | $155.47 | −0.51% | $280.15B | 20.0× | 30.5% | +19.0% |
AZNYSE:AZNAstraZeneca PLC · 🇺🇸 NYSE | $170.91 | −0.96% | $265.07B | 26.1× | 21.1% | +3.3% |
TMNYSE:TMOThermo Fisher Scientific Inc · 🇺🇸 NYSE | $668.58 | −1.18% | $247.21B | 37.1× | 12.6% | +21.2% |
AMNAS:AMGNAmgen Inc · 🇺🇸 NAS | $441.98 | −1.18% | $238.95B | 31.4× | 89.1% | +48.5% |
GINAS:GILDGilead Sciences Inc · 🇺🇸 NAS | $156.60 | −0.38% | $194.18B | 22.9× | 37.5% | +26.7% |
